- Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy
Olga N. Alekseeva et al, 2024, Cancers CrossRef - Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
Annette I.S. van den Berg et al, 2021, Journal of Controlled Release CrossRef - Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
Ryosuke Ono et al, 2021, Molecular Therapy - Oncolytics CrossRef - Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective
Dayananda Kasala et al, 2021, Journal of Controlled Release CrossRef - Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
Selas T.F. Bots et al, 2020, International Journal of Molecular Sciences CrossRef - Intestinal HAdV Infection: Tissue Specificity, Persistence, and Implications for Antiviral Therapy
Karin Kosulin, 2019, Viruses CrossRef - Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry
Kemal Mese et al, 2020, Virology Journal CrossRef - Engineering Oncolytic Adenoviruses with VSVG‐Decorated Tumor Cell Membranes for Synergistically Enhanced Antitumor Therapy
Li‐Li Huang et al, 2023, Advanced Functional Materials CrossRef - Polymeric Systems for Cancer Immunotherapy: A Review
Thai Minh Duy Le et al, 2022, Frontiers in Immunology CrossRef - SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort
Steven M. Schlichtemeier et al, 2019, Journal of Surgical Research CrossRef - Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
Lobke C.M. Hensen et al, 2020, International Journal of Molecular Sciences CrossRef - Overcoming the limitations of locally administered oncolytic virotherapy
JinWoo Hong et al, 2019, BMC Biomedical Engineering CrossRef - Nanomedicine for advanced cancer immunotherapy
Yen N. Diep et al, 2022, Journal of Controlled Release CrossRef